As of the latest Form 4 filed May 19, 2026.
What Harrow Health Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 13 most recent filings for HROW.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | 2026-05-18 | Graves Adrienne L Director | PPurchase | +1.00K | $31.07 | $31.1K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-18 | SILVERNAIL LAUREN P Director | PPurchase | +1.00K | $31.00 | $31.0K | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-14 | BAUM MARK L CHIEF EXECUTIVE OFFICER | PPurchase | +10.0K | $30.20 | $302K | No | Form 4 ↗ |
| 2026-05-15 | 2026-05-14 | BOLL ANDREW R. PRESIDENT AND CFO | PPurchase | +3.50K | $29.90 | $105K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Opaleye Management Inc. 10% owner | SSale | −4.26K | $39.67 | $169K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-04 | Opaleye Management Inc., 10% owner | SSale | −134K | $39.67 | $5.32M | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Opaleye Management Inc., 10% owner | SSale | −1.31K | $39.15 | $51.3K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Opaleye Management Inc., 10% owner | SSale | −59.0K | $39.15 | $2.31M | No | Form 4 ↗ |
| 2026-01-08 | 2026-01-06 | Opaleye Management Inc. 10% owner | SSale | −20.0K | $53.35 | $1.07M | No | Form 4 ↗ |
| 2025-12-16 | 2025-12-12 | BOLL ANDREW R. PRESIDENT AND CFO | FTax | −26.7K | $47.06 | $1.25M | No | Form 4 ↗ |
| 2025-12-16 | 2025-12-12 | BOLL ANDREW R., PRESIDENT AND CFO | MExercise | +60.0K | $3.95 | $237K | No | Form 4 ↗ |
| 2025-12-16 | 2025-12-12 | BAUM MARK L CHIEF EXECUTIVE OFFICER | FTax | −80.0K | $47.06 | $3.76M | No | Form 4 ↗ |
| 2025-12-16 | 2025-12-12 | BAUM MARK L, CHIEF EXECUTIVE OFFICER | MExercise | +180K | $3.95 | $711K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also HROW’s full analysis or the market-wide insider trading feed. The tabs above jump to HROW’s other SEC data.
Source: SEC Form 4 filings for HROW, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.